A. I. Chubarova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. I. Chubarova has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
E.A. Kostomarova
2 shared publicationsMoscow N.F.FIlatov Children’s City Clinical Hospital
2 shared publicationsN.S. Korchagina
2 shared publications- Светлана Вячеславовна Черкасова
Pirogov Russian National Research Medical University
2 shared publications A. A. Moskalenko
Institute of Laboratory Medicine
1 shared publicationA. M. Vedyakov
N. F. Filatov Children’s City Hospital
1 shared publication
Latest Publications
- 24 March 2025
- Published by Alfmed LLC in Medical alphabet
- No. 5,p. 33-42
Advanced and classical parameters of automated complete blood count in the diagnosis of congenital pneumonia in children
Objective. To study the clinical and diagnostic value of the extended parameters of automated complete blood count in patients with congenital pneumonia at different serum concentrations of C-reactive protein (CRP) and procalcitonin (PCT).Materials and methods. A retrospective cohort single-center study was conducted; 203 patients with a confirmed Congenital Pneumonia were included. The extended parameters of automated complete blood count were performed using the hematological analyzer Sysmex XN (Sysmex Co., Japan) and were evaluated according to the serum concentrations of CRP and PCT. All patients were divided into 4 groups: group 1 (serum PCT level 1 ng/ml); group 3 (PCT concentration10 mg/l).Results. The RE-NEUT% index turned out to be 9,3 times, TOTAL IG% 3,9 times, TOTAL IG# 2,9 times higher in the second group compared to the first one (pConclusion. The introduction of such parameters as RE-NEUT%, TOTAL IG%, NE-SFL, and neutrophil index NE-SFL/NE-FSC into routine laboratory practice for examining children with congenital pneumonia or suspected pneumonia may help to reduce the number of examinations of classical biochemical inflammatory markers and improve the assessment of children’s condition both at the admission to hospital and during subsequent monitoring of their condition.
- 24 March 2025
- Published by Alfmed LLC in Medical alphabet
- No. 5,p. 33-42
Advanced and classical parameters of automated complete blood count in the diagnosis of congenital pneumonia in children
Objective. To study the clinical and diagnostic value of the extended parameters of automated complete blood count in patients with congenital pneumonia at different serum concentrations of C-reactive protein (CRP) and procalcitonin (PCT).Materials and methods. A retrospective cohort single-center study was conducted; 203 patients with a confirmed Congenital Pneumonia were included. The extended parameters of automated complete blood count were performed using the hematological analyzer Sysmex XN (Sysmex Co., Japan) and were evaluated according to the serum concentrations of CRP and PCT. All patients were divided into 4 groups: group 1 (serum PCT level 1 ng/ml); group 3 (PCT concentration10 mg/l).Results. The RE-NEUT% index turned out to be 9,3 times, TOTAL IG% 3,9 times, TOTAL IG# 2,9 times higher in the second group compared to the first one (pConclusion. The introduction of such parameters as RE-NEUT%, TOTAL IG%, NE-SFL, and neutrophil index NE-SFL/NE-FSC into routine laboratory practice for examining children with congenital pneumonia or suspected pneumonia may help to reduce the number of examinations of classical biochemical inflammatory markers and improve the assessment of children’s condition both at the admission to hospital and during subsequent monitoring of their condition.
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy Ginekologii, Akušerstva i Perinatologii
- Vol. 24 (2) , 142-152
Intrauterine thrombosis as a manifestation of antiphospholipid syndrome
This article presents a rare case of intrauterine venous thrombosis as a result of antiphospholipid syndrome (APS). The clinical presentation, conditions and incidence, and comorbidities in neonates and children with APS differ significantly from those of adults with APS, leaving many cases of neonatal and pediatric APS undiagnosed. Therefore, a thorough analysis of each confirmed case of APS is necessary to develop new diagnostic criteria as well as to choose adequate therapeutic strategies with minimal risks for patients. Key words: neonatal antiphospholipid syndrome, intrauterine thrombosis, thrombophilia, placenta-related complications
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy Ginekologii, Akušerstva i Perinatologii
- Vol. 24 (2) , 142-152
Intrauterine thrombosis as a manifestation of antiphospholipid syndrome
This article presents a rare case of intrauterine venous thrombosis as a result of antiphospholipid syndrome (APS). The clinical presentation, conditions and incidence, and comorbidities in neonates and children with APS differ significantly from those of adults with APS, leaving many cases of neonatal and pediatric APS undiagnosed. Therefore, a thorough analysis of each confirmed case of APS is necessary to develop new diagnostic criteria as well as to choose adequate therapeutic strategies with minimal risks for patients. Key words: neonatal antiphospholipid syndrome, intrauterine thrombosis, thrombophilia, placenta-related complications
- 1 January 2024
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 22 (3)
Familial cases of microvillus inclusion disease – management experience with home parenteral nutrition
Microvillus inclusion disease or microvillus atrophy (MVID) is a genetic disorder caused by mutations in the MYO5B gene. It is characterized by intractable diarrhea and dependence on parenteral nutrition. This article presents three cases of MVID in children from two families. In case 1, the child was found to have the c.1705A>T mutation (Chr18: 47479677, NM_001080467.2) in homozygote, with both parents being heterozygous carriers. In case 2, both parents were heterozygous carriers of previously undescribed mutations (mother – 782T>C (GRCh37 – 47516865, NM_001080467.2), father – 664A>T (GRCh37 – 47518750, NM_001080467.2)), both heterozygous mutations were inherited by the eldest child (case 2), the maternal heterozygous mutation was inherited by the youngest child (case 3). In all three children, the disease manifested during the first 10 days of life with dehydration, metabolic acidosis, respiratory failure, and oliguria. In case 2, the child died at the age of 5 months. The other two children were followed-up until 4.5 years of age (case 1) and 1 year of age (case 2). Common manifestations included diarrhea of 100 to 300 mL/kg/day, dependence on parenteral nutrition, delay in physical development despite hyperalimentation, frequent episodes of metabolic acidosis, and a tendency to venous thrombosis. In case 1, the child developed secondary Fanconi syndrome at the age of 2.5 years. In all children, the diagnosis was confirmed histologically by the detection of PASpositive material and CD10 marker in the cytoplasm of enterocytes. The article presents the differential diagnosis and therapeutic options for MVID. The observed cases demonstrate the possibility of a typical clinical and morphological presentation of MVID in both homozygous mutation and compound heterozygous mutation and one heterozygous mutation. Key words: microvillus inclusion disease, congenital diarrhea, microvillus atrophy, malabsorption, children, infancy, mucosal atrophy
- 1 January 2024
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 22 (3)
Familial cases of microvillus inclusion disease – management experience with home parenteral nutrition
Microvillus inclusion disease or microvillus atrophy (MVID) is a genetic disorder caused by mutations in the MYO5B gene. It is characterized by intractable diarrhea and dependence on parenteral nutrition. This article presents three cases of MVID in children from two families. In case 1, the child was found to have the c.1705A>T mutation (Chr18: 47479677, NM_001080467.2) in homozygote, with both parents being heterozygous carriers. In case 2, both parents were heterozygous carriers of previously undescribed mutations (mother – 782T>C (GRCh37 – 47516865, NM_001080467.2), father – 664A>T (GRCh37 – 47518750, NM_001080467.2)), both heterozygous mutations were inherited by the eldest child (case 2), the maternal heterozygous mutation was inherited by the youngest child (case 3). In all three children, the disease manifested during the first 10 days of life with dehydration, metabolic acidosis, respiratory failure, and oliguria. In case 2, the child died at the age of 5 months. The other two children were followed-up until 4.5 years of age (case 1) and 1 year of age (case 2). Common manifestations included diarrhea of 100 to 300 mL/kg/day, dependence on parenteral nutrition, delay in physical development despite hyperalimentation, frequent episodes of metabolic acidosis, and a tendency to venous thrombosis. In case 1, the child developed secondary Fanconi syndrome at the age of 2.5 years. In all children, the diagnosis was confirmed histologically by the detection of PASpositive material and CD10 marker in the cytoplasm of enterocytes. The article presents the differential diagnosis and therapeutic options for MVID. The observed cases demonstrate the possibility of a typical clinical and morphological presentation of MVID in both homozygous mutation and compound heterozygous mutation and one heterozygous mutation. Key words: microvillus inclusion disease, congenital diarrhea, microvillus atrophy, malabsorption, children, infancy, mucosal atrophy
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 12 (4)
The method of thrombodynamics in the diagnosis of thrombosis in high-risk newborns
Метод тромбодинамики в диагностике тромбозов у новорожденных высокого риска
- 1 January 2024
- Published by Geotar-Media Publishing Group in Neonatology: News, Opinions, Training
- Vol. 12 (4)
Open AccessThe method of thrombodynamics in the diagnosis of thrombosis in high-risk newborns
Метод тромбодинамики в диагностике тромбозов у новорожденных высокого риска
- 1 January 2023
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 21 (2)
DGAT1-associated protein-losing enteropathy: the first clinical case report in Russia
DGAT1-associated protein-losing enteropathy is a rare autosomal recessive disorder related to congenital diarrhea and associated with a mutation in the DGAT1 gene that encodes the enzyme DGAT1, which is responsible for the final step of triglyceride resynthesis in enterocytes. With insufficient activity of DGAT1 enzyme, fatty acids and diacylglycerols accumulate in the enterocyte, having a cytotoxic effect and causing enterocyte apoptosis. As a result, atrophic enteropathy develops, which is manifested as protein-losing diarrhea from the first months of life, iron deficiency anemia, and vitamin D deficiency. The currently known treatment methods for DGAT1-associated enteropathy are a low-fat diet and parenteral nutrition. This article presents the first genetically confirmed clinical case of DGAT1-associated protein-losing enteropathy in the Russian Federation. Key words: DGAT1, enteropathy, congenital diarrhea, protein-losing diarrhea, children
- 1 January 2023
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 21 (2)
DGAT1-associated protein-losing enteropathy: the first clinical case report in Russia
DGAT1-associated protein-losing enteropathy is a rare autosomal recessive disorder related to congenital diarrhea and associated with a mutation in the DGAT1 gene that encodes the enzyme DGAT1, which is responsible for the final step of triglyceride resynthesis in enterocytes. With insufficient activity of DGAT1 enzyme, fatty acids and diacylglycerols accumulate in the enterocyte, having a cytotoxic effect and causing enterocyte apoptosis. As a result, atrophic enteropathy develops, which is manifested as protein-losing diarrhea from the first months of life, iron deficiency anemia, and vitamin D deficiency. The currently known treatment methods for DGAT1-associated enteropathy are a low-fat diet and parenteral nutrition. This article presents the first genetically confirmed clinical case of DGAT1-associated protein-losing enteropathy in the Russian Federation. Key words: DGAT1, enteropathy, congenital diarrhea, protein-losing diarrhea, children